— Know what they know.
Not Investment Advice

INNO.CN CNQ

InnoCan Pharma Corporation
1W: -7.6% 1M: +1.4% 3M: -17.9% YTD: -69.4% 1Y: -84.6% 3Y: -84.6% 5Y: -93.2%
C$2.20 ($1.54)
-0.15 (-6.38%)
 
CNQ · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 53 · C$9.9M mcap · 4M float · 0.039% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market CapC$9.9M ($6.9M)
52W Range2-21
Volume154
Avg Volume1,407
Beta-0.22
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOIris Bincovich
Employees11
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2019-09-25
1015, 926 – 5 Avenue SW
Calgary, AB T2P 0N7
CA
403 777 1519
About InnoCan Pharma Corporation

InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms